NeuroRx is dedicated to working with the pharmaceutical industry to facilitate clinical trials of new drugs for multiple sclerosis (MS) and other neurological diseases. NeuroRx provides professional management of all MRI-related study activities and promptly delivers precise MRI outcome measurements that are performed in a regulatory compliant environment. We are specialized in logistics of scan handling and tracking and can provide this service exclusively, if needed.
NeuroRx uses advanced image analysis techniques to provide precise outcome data that maximize study power. Images are corrected for inhomogeneity and co-registered for perfect re-alignment and increased precision. Analyses are conducted in 3D, rather than on slices, so that information can be properly related to structures that span multiple slices. Customized automatic segmentation techniques are combined with expert supervision to maximize the precision of outcome measures related to both lesional and non-lesional pathology, as well as brain volume changes (atrophy).
NeuroRx also has extensive experience with acquisition and analysis of non-conventional MRI techniques, including magnetization transfer imaging (MTR) and magnetic resonance spectroscopy (MRS).
NeuroRx understands the need for efficient and effective trial design and conduct. NeuroRx can provide advice on the choice of MRI metrics, facilitate site startup and provide regular reports.
NeuroRx Research has experience performing centralized MRI analysis for multicenter clinical trials in the countries listed below.
Algeria, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Lithuania, Macedonia, Malaysia, Mexico, Republic of Moldova, Morocco, Netherlands, New Zealand, Norway, Panama, Peru, Philippines, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, United States.